Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Electroconvulsive therapy
9 evidence topics · 10 sources
CANMAT guideline: efficacy, course, and cognitive effects of ECT
“ECT remains one of the most effective treatment options for patients with TRD.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“ECT has demonstrated evidence of efficacy and tolerability in the treatment of depressive episodes, with response rates ranging from 65% to 75%” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“An acute course of ECT usually requires 6 to 12 sessions, with no difference in response outcomes between sessions given twice or thrice weekly” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Adverse effects on cognition are of most concern, although modern ECT techniques, including unilateral electrode placement and refined electrical dosing, have reduced both the incidence and severity of cognitive side effects.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Nevertheless, some patients report significant and distressing gaps in autobiographical memory long after ECT, and the discrepancy between cognitive performance and subjective memory dysfunction remains controversial.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Although ECT has high response rates during acute treatment, recurrence occurs in 60% to 80% of patients at 6-month follow-up.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
VA/DoD guideline: ECT for severe depression
NICE guideline: ECT for severe depression
Meta-analysis of ECT compared with simulated ECT and pharmacotherapy
“Real ECT was significantly more effective than simulated ECT (six trials, 256 patients, standardised effect size [SES] -0.91, 95% CI -1.27 to -0.54).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Treatment with ECT was significantly more effective than pharmacotherapy (18 trials, 1144 participants, SES -0.80, 95% CI -1.29 to -0.29).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
ECT remission after antidepressant pharmacotherapy failure
Network meta-analysis: response with ECT compared with sham
ELEKT-D: ECT compared with intravenous ketamine, including memory outcomes
“A total of 55.4% of the patients in the ketamine group and 41.2% of those in the ECT group had a response (difference, 14.2 percentage points; 95% confidence interval, 3.9 to 24.2; P<0.001 for the noninferiority of ketamine to ECT).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“ECT appeared to be associated with a decrease in memory recall after 3 weeks of treatment (mean [±SE] decrease in the T-score for delayed recall on the Hopkins Verbal Learning Test-Revised, -0.9±1.1 in the ketamine group vs. -9.7±1.2 in the ECT group; scores range from -300 to 200, with higher scores indicating better function) with gradual recovery during follow-up.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Objective cognitive performance after ECT
“Twenty-four cognitive variables (84 studies, 2981 patients) were meta-analyzed. No standardized retrograde amnesia tests were identified.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Significant decreases in cognitive performance were observed 0 to 3 days after ECT in 72% of variables” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Cognitive abnormalities associated with ECT are mainly limited to the first 3 days posttreatment.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Relapse after successful ECT
“In modern era studies of continuation pharmacotherapy, 51.1% (95% CI=44.7–57.4%) of patients relapsed by 12 months following successful initial treatment with ECT, with the majority (37.7%, 95% CI=30.7–45.2%) relapsing within the first 6 months.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote